Facebook (FB) Tops Q3 EPS by 31c
Facebook (NASDAQ: FB) reported Q3 EPS of $1.59, $0.31 better than the analyst estimate of $1.28. Revenue for the quarter came in at $10.33 billion versus the consensus estimate of $9.84 billion
- Daily active users (DAUs) – DAUs were 1.37 billion on average for September 2017, an increase of 16% year-over-year.
- Monthly active users (MAUs) – MAUs were 2.07 billion as of September 30, 2017, an increase of 16% year-over-year.
- Mobile advertising revenue – Mobile advertising revenue represented approximately 88% of advertising revenue for the third quarter of 2017, up from approximately 84% of advertising revenue in the third quarter of 2016.
- Capital expenditures – Capital expenditures for the third quarter of 2017 were $1.76 billion.
- Cash and cash equivalents and marketable securities – Cash and cash equivalents and marketable securities were $38.29 billion at the end of the third quarter of 2017.
- Headcount – Headcount was 23,165 as of September 30, 2017, an increase of 47% year-over-year
For earnings history and earnings-related data on Facebook (FB) click here.
Wed, 01 Nov 2017 16:05:00 -0400
Copyright (c) 2017 StreetInsider.com
Este Post ha recibido un Upvote desde la cuenta del King: @dineroconopcion, El cual es un Grupo de Soporte mantenido por 5 personas mas que quieren ayudarte a llegar hacer un Top Autor En Steemit sin tener que invertir en Steem Power. Te Gustaria Ser Parte De Este Projecto?
This Post has been Upvote from the King's Account: @dineroconopcion, It's a Support Group by 5 other people that want to help you be a Top Steemit Author without having to invest into Steem Power. Would You Like To Be Part of this Project?
This post has been ranked within the top 50 most undervalued posts in the second half of Nov 02. We estimate that this post is undervalued by $17.47 as compared to a scenario in which every voter had an equal say.
See the full rankings and details in The Daily Tribune: Nov 02 - Part II. You can also read about some of our methodology, data analysis and technical details in our initial post.
If you are the author and would prefer not to receive these comments, simply reply "Stop" to this comment.